Image Credit: DukiPH / Shutterstock.com Introduction Orforglipron is an orally bioavailable next-generation glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) that has emerged as a potential alternative to injectable agents like semaglutide based on early Phase 1, 2, and 3 clinical trials demonstrating glucose-lowering and weight-loss efficacy without the need for injection-based delivery
Types of garlic products available in the market Garlic products can be categorized under different categories like garlic powder, garlic oil macerate, aged garlic extract and garlic essential oil
Sustainable, Low-Dose Use Microdosing preserves core health advantages while minimizing side effects
First Drug Approved for Obesity-Related Sleep Apnea June 2024 In June 2024, the FDA approved Zepbound (tirzepatide) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity making it the first drug ever approved for this indication
Indeed it has been hypothesized that depression and vascular disease may be different manifestations of the same genetic substrates 79
Virmani A, Pinto L, Binienda Z, Ali S (2013) Food, nutrigenomics, and neurodegeneration neuroprotection by what you eat
